Education
About Us
Working with TipRanks
Follow Us
Cbd Life Sciences Inc. (CBDL)
:CBDL
Total Valuation
CBD Life Sciences has a market cap or net worth of $563.09K. The enterprise value is $368.85K.
Market Cap$563.09K
Enterprise Value$368.85K
Share Statistics
CBD Life Sciences has 1,876,971,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,876,971,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CBD Life Sciences’s return on equity (ROE) is -1.93 and return on invested capital (ROIC) is -192.86%.
Return on Equity (ROE)-1.93
Return on Assets (ROA)-1.86
Return on Invested Capital (ROIC)-192.86%
Return on Capital Employed (ROCE)-1.93
Revenue Per Employee36.30K
Profits Per Employee-252.40K
Employee Count3
Asset Turnover0.27
Inventory Turnover3.73
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio1.97
Price to Fair Value3.94
Price to FCF-333.03
Price to Operating Cash Flow-549.56
PEG Ratio0.06
Income Statement
In the last 12 months, CBD Life Sciences had revenue of 108.89K and earned -757.19K in profits. Earnings per share was 0.00.
Revenue108.89K
Gross Profit-9.89K
Operating Income-757.19K
Pretax Income-757.19K
Net Income-757.19K
EBITDA-701.63K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -989.00 and capital expenditures 0.00, giving a free cash flow of -989.00 billion.
Operating Cash Flow-989.00
Free Cash Flow-989.00
Free Cash Flow per Share>-0.01
Dividends & Yields
CBD Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-122.02
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
CBD Life Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CBD Life Sciences as a current ratio of 17.18, with Debt / Equity ratio of 0.00%
Current Ratio17.18
Quick Ratio14.93
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CBD Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CBD Life Sciences EV to EBITDA ratio is -2.20, with an EV/FCF ratio of -2.64.
EV to Sales14.16
EV to EBITDA-2.20
EV to Free Cash Flow-2.64
EV to Operating Cash Flow-2.64
Balance Sheet
CBD Life Sciences has $82.00 in cash and marketable securities with $0.00 in debt, giving a net cash position of -$82.00 billion.
Cash & Marketable Securities$82.00
Total Debt$0.00
Net Cash-$82.00
Net Cash Per Share>-$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 24.93%, with operating margin of -695.36%, and net profit margin of -695.36%.
Gross Margin24.93%
Operating Margin-695.36%
Pretax Margin-695.36%
Net Profit Margin-695.36%
EBITDA Margin-644.34%
EBIT Margin-695.36%
Analyst Forecast
The average price target for CBD Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―